Conformal Medical

Conformal Medical, Inc. is a medical device company based in Nashua, New Hampshire. The company specializes in innovative technologies aimed at preventing strokes in patients with non-valvular atrial fibrillation (AFib) by sealing the left atrial appendage (LAA) without the need for long-term anticoagulant medications. Founded with venture backing, Conformal Medical has recently secured $32 million in funding and is recognized as the Powerhouse MedTech Company of the Year by the New England Venture Capital Association. The flagship product, the CLAAS® System, includes the next-generation AcuFORM™ System. This proprietary device features a foam-based architecture that accommodates various LAA anatomies using just two sizes. Conformal Medical is advancing toward U.S. FDA pre-market approval through pivotal trials, having treated over 100 patients with promising results. The company focuses on providing solutions for patients at risk of stroke and healthcare professionals performing LAAO procedures, aiming to make LAA closure a more efficient outpatient intervention.